Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

16 structures for P23193

Entry ID Method Resolution Chain Position Source
1TFI NMR - A 252-301 PDB
3NDQ X-ray 193 A A 131-232 PDB
5IY6 EM 720 A U 1-301 PDB
5IY7 EM 860 A U 1-301 PDB
5IY8 EM 790 A U 1-301 PDB
5IYA EM 540 A U 1-301 PDB
5IYB EM 390 A U 1-301 PDB
5IYC EM 390 A U 1-301 PDB
6O9L EM 720 A U 1-301 PDB
6ZUY NMR - A 1-79 PDB
6ZV4 NMR - A 1-77 PDB
7CNF NMR - A 1-96 PDB
7UNC EM 300 A O 1-301 PDB
7UND EM 300 A O 1-301 PDB
8A40 EM 300 A U 1-301 PDB
AF-P23193-F1 Predicted AlphaFoldDB

192 variants for P23193

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1375131410
CA370980505
3 D>G No ClinGen
TOPMed
gnomAD
CA370980507
rs1223834008
3 D>N No ClinGen
gnomAD
rs1445503734
CA370980498
4 E>A No ClinGen
gnomAD
CA370980501
rs1306655897
4 E>K No ClinGen
gnomAD
CA370980478
rs1459863450
7 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA4750260
rs773210177
10 K>E No ClinGen
ExAC
gnomAD
rs978660068
CA177216006
11 K>Q No ClinGen
TOPMed
CA370980441
rs1221851816
12 M>I No ClinGen
TOPMed
rs1405825593
CA370980447
12 M>V No ClinGen
TOPMed
gnomAD
rs768622226
CA4750259
13 D>G No ClinGen
ExAC
gnomAD
rs1454824200
CA370980430
14 K>Q No ClinGen
gnomAD
TCGA novel 15 M>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1255362812
CA370980421
15 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA4750256
rs745685647
20 N>K No ClinGen
ExAC
TOPMed
rs775504643
CA4750257
20 N>S No ClinGen
ExAC
gnomAD
rs1586048301
CA370980378
21 A>T No ClinGen
Ensembl
CA370980373
rs1255443914
21 A>V No ClinGen
TOPMed
CA370980355
rs1254012570
22 A>V No ClinGen
TOPMed
rs1189219542
CA370980344
24 A>G No ClinGen
gnomAD
CA370980343
rs1189219542
24 A>V No ClinGen
gnomAD
TCGA novel 27 L>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 32 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1273767520
CA370980271
34 I>M No ClinGen
TOPMed
rs747721723
CA4750230
36 M>I No ClinGen
ExAC
gnomAD
rs200607231
CA4750231
36 M>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1316035514
CA370980228
41 L>P No ClinGen
gnomAD
CA370980219
rs1277529452
42 Q>H No ClinGen
gnomAD
CA370980199
rs1221033268
44 T>A No ClinGen
TOPMed
CA370980198
rs1221033268
44 T>S No ClinGen
TOPMed
rs1279411676
CA370980191
45 R>K No ClinGen
TOPMed
rs906658429
CA177199580
46 I>V No ClinGen
Ensembl
TCGA novel 47 G>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA370980181
rs1415755975
47 G>R No ClinGen
gnomAD
CA177199571
rs1042599521
48 M>L No ClinGen
TOPMed
gnomAD
rs945554136
CA177199554
49 S>L No ClinGen
Ensembl
TCGA novel 51 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4750199
rs766368998
52 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA4750198
rs762620701
52 A>V No ClinGen
ExAC
gnomAD
CA4750196
rs764788189
53 I>V No ClinGen
ExAC
gnomAD
CA370980136
rs1258249801
54 R>C No ClinGen
gnomAD
rs1212522845
CA370980128
55 K>R No ClinGen
gnomAD
CA4750194
rs776431199
65 L>F No ClinGen
ExAC
gnomAD
CA370980037
rs1193354565
68 S>F No ClinGen
TOPMed
CA370980031
rs1256739538
69 L>H No ClinGen
gnomAD
rs1320398592
CA370980034
69 L>I No ClinGen
gnomAD
TCGA novel 71 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA370979986
rs1293366513
75 K>R No ClinGen
TOPMed
gnomAD
CA370979970
rs1425220041
77 L>F No ClinGen
TOPMed
CA370979150
rs1362275773
79 G>R No ClinGen
TOPMed
TCGA novel 81 S>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4750176
rs61748783
82 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs1159369417
CA370979111
82 T>N No ClinGen
gnomAD
rs61748783
CA177194144
82 T>P No ClinGen
ExAC
TOPMed
gnomAD
CA4750173
rs375610136
85 D>E No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs61748782
CA370979056
86 L>F No ClinGen
ExAC
gnomAD
rs61748782
CA4750172
86 L>V No ClinGen
ExAC
gnomAD
rs1219946984
CA370979025
88 E>G No ClinGen
gnomAD
rs771234542
CA4750170
90 K>Q No ClinGen
ExAC
gnomAD
TCGA novel 92 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1288448709
CA370978951
93 P>A No ClinGen
TOPMed
gnomAD
rs1054812114
CA177194116
94 A>P No ClinGen
TOPMed
CA177194110
rs764311439
94 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA4750166
rs144176316
95 I>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs770047485
CA4750165
97 S>L No ClinGen
ExAC
gnomAD
rs903627179
CA177194066
99 N>H No ClinGen
TOPMed
CA177194059
rs1043890740
99 N>S No ClinGen
TOPMed
CA4750162
rs755021803
101 P>R No ClinGen
ExAC
gnomAD
rs986979452
CA177194035
104 R>* No ClinGen
TOPMed
rs757079676
CA4750159
105 E>G No ClinGen
ExAC
gnomAD
rs61740799
CA177194021
106 E>K No ClinGen
Ensembl
CA370978593
rs754476656
111 G>C No ClinGen
ExAC
TOPMed
gnomAD
CA4750135
rs754476656
111 G>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1338535367
CA370978588
112 N>H No ClinGen
TOPMed
gnomAD
CA4750134
rs751076267
112 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs1337009716
CA370978579
113 V>E Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA370978573
rs1586006296
114 S>N No ClinGen
Ensembl
CA370978569
rs1381571651
114 S>R No ClinGen
gnomAD
CA370978566
rs1301271821
115 N>H No ClinGen
gnomAD
rs557599447
CA4750133
115 N>K No ClinGen
1000Genomes
ExAC
gnomAD
CA370978557
rs1401400213
116 R>I No ClinGen
gnomAD
rs774735589
CA4750132
118 D>G No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 119 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs773716419
CA4750131
120 T>A No ClinGen
ExAC
gnomAD
rs371306322
CA4750130
121 N>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1202415874
CA370978503
122 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs776875502
CA4750128
123 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs776875502
CA370978495
123 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs747091310
CA4750127
123 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs747091310
CA4750126
123 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs190781971
CA4750125
124 D>N No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA370978450
rs374069934
126 Y>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1238499013
CA370978456
126 Y>S No ClinGen
gnomAD
CA177189408
rs933959208
131 P>L No ClinGen
Ensembl
rs1005850753
CA177189411
131 P>S No ClinGen
TOPMed
CA4750121
rs199869556
COSM273574
132 R>W Variant assessed as Somatic; 0.0 impact. pancreas large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA177189406
rs1037056970
133 A>T No ClinGen
Ensembl
CA4750120
rs769590882
134 P>A No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel
rs940240240
CA177189393
135 S>R Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
gnomAD
NCI-TCGA
rs747930544
CA4750119
136 T>I No ClinGen
ExAC
gnomAD
rs780873013
CA370978321
137 S>A No ClinGen
ExAC
gnomAD
rs780873013
CA4750118
137 S>T No ClinGen
ExAC
gnomAD
CA4750116
rs751060849
139 S>F No ClinGen
ExAC
gnomAD
rs554296579
CA4750117
139 S>P No ClinGen
1000Genomes
ExAC
gnomAD
CA4750114
rs757921440
140 V>A No ClinGen
ExAC
gnomAD
CA370978256
rs1164293312
142 L>F No ClinGen
gnomAD
rs1442989856
CA370978235
144 C>G No ClinGen
TOPMed
CA370978221
rs1457997775
144 C>W No ClinGen
gnomAD
rs910169256
CA177189345
145 R>K No ClinGen
Ensembl
rs201165811
CA4750113
148 L>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs765767710
CA4750112
149 A>V No ClinGen
ExAC
gnomAD
CA4750111
rs754205500
150 A>S No ClinGen
ExAC
gnomAD
CA4750110
rs754205500
150 A>T No ClinGen
ExAC
gnomAD
CA370978142
rs1380752760
150 A>V No ClinGen
gnomAD
rs764364857
COSM263989
CA4750109
153 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs200590980
CA4750105
155 G>A No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs200590980
CA4750106
155 G>E No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs200590980
CA4750108
155 G>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1172916870
CA370977965
156 D>G No ClinGen
gnomAD
rs1210291581
CA370978076
156 D>H No ClinGen
TOPMed
gnomAD
TCGA novel 156 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA370977961
rs1172916870
156 D>V No ClinGen
gnomAD
rs1210291581
CA370978074
156 D>Y No ClinGen
TOPMed
gnomAD
CA177188507
rs1047179936
157 D>N No ClinGen
TOPMed
gnomAD
rs1047179936
CA370977952
157 D>Y No ClinGen
TOPMed
gnomAD
CA4750084
rs544980860
158 Y>C No ClinGen
1000Genomes
ExAC
gnomAD
rs544980860
CA370977931
158 Y>S No ClinGen
1000Genomes
ExAC
gnomAD
rs923177617
CA177188499
159 I>L No ClinGen
TOPMed
gnomAD
CA4750083
rs774628452
161 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs769761810
CA4750082
164 D>V No ClinGen
ExAC
gnomAD
rs1465897199
CA370977842
165 E>A No ClinGen
TOPMed
TCGA novel 167 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1025672723
CA177188443
170 S>C No ClinGen
TOPMed
rs1025672723
CA177188459
170 S>F No ClinGen
TOPMed
rs1269322059
CA370977701
175 A>T No ClinGen
gnomAD
CA370977315
rs1471932982
175 A>V No ClinGen
gnomAD
rs536110770
CA4750056
176 I>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA370977281
rs1179630541
178 Q>R No ClinGen
gnomAD
CA4750055
rs776395821
182 N>H No ClinGen
ExAC
gnomAD
CA370977220
rs1181195458
183 T>A No ClinGen
TOPMed
CA370977215
rs1236920540
183 T>R No ClinGen
gnomAD
rs1244664983
CA370977198
184 D>E No ClinGen
TOPMed
CA177186120
rs939960872
185 M>I No ClinGen
TOPMed
rs1204359915
CA370977156
187 Y>C No ClinGen
gnomAD
rs764136240
CA4750054
191 V>I No ClinGen
ExAC
gnomAD
rs760444974
CA370977096
192 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs760444974
CA4750053
192 R>G No ClinGen
ExAC
gnomAD
CA4750052
rs775322544
192 R>Q No ClinGen
ExAC
gnomAD
rs771708577
CA4750051
193 S>N No ClinGen
ExAC
TOPMed
gnomAD
CA4750049
rs774068260
195 I>M No ClinGen
ExAC
CA4750050
rs745459376
195 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA177186093
rs908195188
199 K>* No ClinGen
TOPMed
rs1378782348
CA370976995
200 D>V No ClinGen
gnomAD
CA16040541
rs1306991920
201 A>T No ClinGen
TOPMed
gnomAD
TCGA novel 203 N>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs770305078
CA4750048
205 N>D No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 206 L>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs748867181
CA4750047
209 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA4750046
rs778119736
211 L>P No ClinGen
ExAC
gnomAD
rs1365212746
CA370976862
COSM3395357
211 L>V pancreas [Cosmic] No ClinGen
cosmic curated
gnomAD
rs1446342162
CA370976842
212 C>W No ClinGen
TOPMed
CA177186044
rs981113380
213 G>R No ClinGen
TOPMed
gnomAD
CA370976819
rs1319145051
214 N>T No ClinGen
TOPMed
rs755404716
CA4750041
216 P>L No ClinGen
ExAC
gnomAD
CA4750042
rs755404716
216 P>R No ClinGen
ExAC
gnomAD
rs748514928
CA4750043
216 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs575259192
CA177185996
218 D>E No ClinGen
TOPMed
gnomAD
rs751685890
CA4750040
225 A>T No ClinGen
ExAC
gnomAD
rs963722279 226 E>= Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs1192788856
CA370976357
227 E>K No ClinGen
TOPMed
rs772596271
CA177181794
236 M>T No ClinGen
Ensembl
CA4750020
rs200499230
237 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA370976280
COSM1457514
rs1288459076
237 R>W Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
rs758708704
CA4750018
238 K>N No ClinGen
ExAC
gnomAD
rs1174589663
CA370976269
239 N>D No ClinGen
gnomAD
CA4750017
rs750465931
239 N>T No ClinGen
ExAC
gnomAD
CA370976246
rs1460555619
242 K>R No ClinGen
gnomAD
rs762271675
CA177181770
248 H>Y Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA177181762
rs965028555
252 K>R No ClinGen
TOPMed
gnomAD
rs368515547
CA4750014
254 G>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4750013
rs767481992
261 F>L No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 263 C>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 266 C>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs759228331
CA4750012
269 K>R No ClinGen
ExAC
gnomAD
CA4750011
rs751428994
270 N>S No ClinGen
ExAC
gnomAD
CA370976031
rs1370259928
272 T>I No ClinGen
TOPMed
CA370976029
rs1220582275
273 Y>H No ClinGen
TOPMed
CA370986896
rs1313130606
276 V>L No ClinGen
gnomAD
CA370986818
rs1378027814
281 A>T Variant assessed as Somatic; 4.668e-05 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA4749997
rs201107451
285 M>V No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 287 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA370986703
rs1390156019
289 V>F No ClinGen
gnomAD
CA4749994
rs558253108
293 E>Q No ClinGen
ExAC
TOPMed
gnomAD

1 associated diseases with P23193

Without disease ID

4 regional properties for P23193

Type Name Position InterPro Accession
domain Zinc finger, TFIIS-type 259 - 300 IPR001222
domain Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type 5 - 79 IPR003617
domain Transcription elongation factor S-II, central domain 136 - 256 IPR003618
domain Transcription factor IIS, N-terminal 3 - 80 IPR017923

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
nucleolus A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
transcription factor TFIID complex A complex composed of TATA binding protein (TBP) and TBP associated factors (TAFs); the total mass is typically about 800 kDa. Most of the TAFs are conserved across species. In TATA-containing promoters for RNA polymerase II (Pol II), TFIID is believed to recognize at least two distinct elements, the TATA element and a downstream promoter element. TFIID is also involved in recognition of TATA-less Pol II promoters. Binding of TFIID to DNA is necessary but not sufficient for transcription initiation from most RNA polymerase II promoters.

2 GO annotations of molecular function

Name Definition
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
zinc ion binding Binding to a zinc ion (Zn).

4 GO annotations of biological process

Name Definition
DNA-templated transcription The synthesis of an RNA transcript from a DNA template.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
transcription by RNA polymerase II The synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).
transcription elongation by RNA polymerase II promoter The extension of an RNA molecule after transcription initiation and promoter clearance at an RNA polymerase II promoter by the addition of ribonucleotides catalyzed by RNA polymerase II.

7 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
A5PKE4 TCEANC2 Transcription elongation factor A N-terminal and central domain-containing protein 2 Bos taurus (Bovine) PR
Q96MN5 TCEANC2 Transcription elongation factor A N-terminal and central domain-containing protein 2 Homo sapiens (Human) PR
Q8R2M0 Tceanc2 Transcription elongation factor A N-terminal and central domain-containing protein 2 Mus musculus (Mouse) PR
P23881 Tcea3 Transcription elongation factor A protein 3 Mus musculus (Mouse) PR
P10711 Tcea1 Transcription elongation factor A protein 1 Mus musculus (Mouse) PR
Q5XIC7 Tceanc2 Transcription elongation factor A N-terminal and central domain-containing protein 2 Rattus norvegicus (Rat) PR
P52652 T24H10.1 Putative transcription elongation factor S-II Caenorhabditis elegans PR
10 20 30 40 50 60
MEDEVVRFAK KMDKMVQKKN AAGALDLLKE LKNIPMTLEL LQSTRIGMSV NAIRKQSTDE
70 80 90 100 110 120
EVTSLAKSLI KSWKKLLDGP STEKDLDEKK KEPAITSQNS PEAREESTSS GNVSNRKDET
130 140 150 160 170 180
NARDTYVSSF PRAPSTSDSV RLKCREMLAA ALRTGDDYIA IGADEEELGS QIEEAIYQEI
190 200 210 220 230 240
RNTDMKYKNR VRSRISNLKD AKNPNLRKNV LCGNIPPDLF ARMTAEEMAS DELKEMRKNL
250 260 270 280 290 300
TKEAIREHQM AKTGGTQTDL FTCGKCKKKN CTYTQVQTRS ADEPMTTFVV CNECGNRWKF
C